The prevalence of hepatitis C virus (HCV) infection amongst a group of intravenous drug users (IVDUs) resident in West Suffolk (East Anglia, England) was investigated and compared with the prevalence of infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV). In addition, both
Sexual transmission of hepatitis C virus and HIV-1 infection in female intravenous drug users
β Scribed by A. Salvaggio; M. Conti; A. Albano; A. Pianetti; M. L. Muggiasca; M. Re; L. Salvaggio
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 506 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0393-2990
No coin nor oath required. For personal study only.
β¦ Synopsis
We examined the relationship between the presence of antibody to HCV and sexually transmitted diseases in 151 female, intravenous drug users aged 17-43 years. Anti-HCV was present in 49 of 66 HIV-l-negative women (74.2%), and 63 of 85 HIV-l-positive women (74.1%). Anti-HCV seropositivity was significantly related to sexually transmitted infections (Ureaplasma urealyticum infections excluded) in HIV-l-seronegative women, but not in HIV-l-positive women. Also, in HIV-l-negative subjects, Trichomonas vaginalis infections (and infections with M. hominis) were significantly related to anti-HCV seropositivity, and a positive relation between the number of sexual partners and the presence of anti-HCV was demonstrated. In HIV-l-positive subjects a shared use of needles and syringes was more likely, and an increased parenteral exposure to HCV may decrease the relative contribution by sexual transmission. However, in HIV-l-negative subjects, sexual transmission of HCV appears to be both a possible and important means of transmission.
π SIMILAR VOLUMES
## Abstract The epidemiology and impact of occult HBV infection in intravenous drug users remain largely unknown. The aim of the study was to investigate the prevalence of occult HBV infection among intravenous drug users in Taiwan. Molecular assays were used to determine the level of serum HBV DNA
## Abstract Intravenous drug users constitute a group at risk for hepatitis C virus (HCV) infection. Today, no data are available on the molecular epidemiology of HCV in Bulgaria despite the fact that in recent years the incidence of acute hepatitis C infection among Bulgarian intravenous drug user
## Abstract The aim of this study was to describe the distribution of hepatitis C genotypes among intravenous drug users in northβeastern Poland. The study group included intravenous drug users recruited at a drug treatment center and a clinic for HIVβinfected patients. HCV infection was confirmed